Banner - NPPA Connect

NP/PA Connect
News
Media
Conferences
Events
Publication
CME/CE
Resources
Editorial Advisory Board
Partners
Subscribe

|Articles|March 29, 2022

New Solutions for Adult Acne

Author(s)Mary Scoviak, Managing Editor

Once synonymous with puberty, acne is a growing concern for adults—particularly for women—from the 20s to well into their 40s. Christopher Bunick, MD, PhD delved into treatment options for this increasing patient population at the American Academy of Dermatology 2022 Annual Meeting.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

Switching from Biologics to Upadacitinib Yields Progressive Improvements in Moderate to Severe AD

ByMarie Bosslett, Assistant Editor

July 21st 2026

New Review Confirms How Nonmedicated Skin Care Vehicles Drive Clinical Improvement

ByMarie Bosslett, Assistant Editor

July 17th 2026

Higher Cumulative Isotretinoin Dose May Reduce Acne Relapse

ByShannon Heaning, Content Associate

July 8th 2026

Efficacy and Hydration Benefits of a Barrier-Conscious Dermocosmetic Regimen for Acne

ByMarie Bosslett, Assistant Editor

July 7th 2026

LEADderm Enters Third Year with Focus on Leadership, Values, and Reinvigoration

ByJennifer Soung, MD,Marie Bosslett, Assistant Editor

July 6th 2026

Latest CME

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Jerry Bagel, MD, MS

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Douglas DiRuggiero, DMSc, MHS, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Trending on Dermatology Times

Switching from Biologics to Upadacitinib Yields Progressive Improvements in Moderate to Severe AD

Systemic JAK Inhibitors for Vitiligo: Emerging Clinical Trial Data and Safety Considerations

Real-World Study Finds Experienced Dermatologists Outperform AI in Skin Cancer Diagnosis

How Dermatologists Can Incorporate GLP-1 Receptor Agonists Into Psoriasis Care

New Consensus Defines Remission, Disease Activity in Atopic Dermatitis